# 20/20 Biolabs Inc. (AIDX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AIDX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.08M | $ -3.68M | $ -1.89M | N/A | $ 3.16M |
| 2025 | $ 979.1K | $ -2.18M | $ -918.8K | $ 1.28B | $ -19.2K |
| 2024 | $ 942.9K | $ -3.28M | $ -563.9K | $ 1.51M | $ 1.53M |
| 2023 | $ 816.7K | $ -4.01M | $ -2.75M | $ 1.23M | $ 4.29M |
| 2022 | N/A | N/A | N/A | $ 1.41M | $ 9.37M |
| 2021 | N/A | N/A | N/A | $ 1.27M | $ 6.89M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 0.94 |
| Current Ratio | 1.99 |

## Other views

- [Metrics](https://sponda.capital/en/AIDX.md)
- [Charts](https://sponda.capital/en/AIDX/charts.md)
- [Compare](https://sponda.capital/en/AIDX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.